Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook
Key Highlights
- ➤FY 2026 EBITDA guidance $1.1-$1.125B, EPS guidance $0.76-$0.80
- ➤Q3 net sales $1.591B, down 9% year over year
- ➤Q3 adjusted operating EBITDA $222M, down 17% year over year
- ➤Latin America organic sales declined 31%, driven by Brazil market weakness
- ➤Board authorized Corteva’s first common dividend post spin
Expert Statements
Luke Kissam, CEO of Corteva
“We executed well against the things we can control. New products performed strongly, productivity delivered, and we generated broad-based organic growth outside Latin America. The pressure remains concentrated. Acetochlor pricing in the U.S. was consistent with our expectations, but Brazil was materially weaker than anticipated. While those conditions are reflected in our updated outlook, our strategy has not changed. Innovation, productivity and disciplined execution remain the foundation for sustainable long-term growth.”
Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook PR Newswire
* Third-quarter results reflect strong new product sales growth and continued operational excellence, helping mitigate broader market headwinds * Pricing pressure was concentrated in North America and Latin America, reflecting an anticipated acetochlor headwind and competitive dynamics on molecules late in their lifecycle, respectively * Full-year 2026 guidance updated reflecting weaker market conditions than previously anticipated in Brazil INDIANAPOLIS, Nov. 11, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) ("Corteva" or the "Company") today reported financial results for the third quarter and nine months ended September 30, 2026.
Get started
Create a free account to read the full story.